Pharmaceutical Drug Targets and Diseases: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 164: | Line 164: | ||
***[[Acid-beta-glucosidase]] | ***[[Acid-beta-glucosidase]] | ||
***[[Molecular_playground/beta_2_microglobulin|ß-2 Microglobulin]] | ***[[Molecular_playground/beta_2_microglobulin|ß-2 Microglobulin]] | ||
***[[HMG-CoA Reductase]] | |||
***[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | ***[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | ||
***[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | ***[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA) 2]] | ||